Jazz Pharmaceuticals To Pay $57M To End DOJ Inquiry
Ireland's Jazz Pharmaceuticals PLC has agreed to pay $57 million to resolve a U.S. Department of Justice investigation into its purported financial support of nonprofits that help Medicare patients cover out-of-pocket...To view the full article, register now.
Already a subscriber? Click here to view full article